is tirzepatide a peptide hormone Tirzepatide, New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review AOD-9604 vs MOTS-c vs Tesamorelin

Phase 4: Therapeutic dose (Weeks 13-16) Dose: 8 mg or 9 mg once weekly What to expect: Strong appetite suppression Significant ongoing weight loss Possible temporary GI flare during escalation Many reach 10-15% weight loss by this phase Tips: This is where most people stabilize 8 mg may be sufficient for manyhigher isn't always better Continue lifestyle optimization Regular check-ins with healthcare provider Phase 5: Maximum dose (Week 17+) Dose: 12 mg once weekly (if tolerated and needed) What to expect: Maximum therapeutic effect Continued weight loss (averaging 20%+ by 48 weeks in trials) GI side effects may be manageable or may persist Some achieve 25-30%+ weight loss Tips: Not everyone needs to reach 12 mg Lower doses may provide sufficient results Balance efficacy with tolerability Maintenance may involve dose reduction For general peptide dosing principles, see our peptide dosage calculator guide

2024 Jun;44(3):324-332

Kunutsor: conceptualization, methodology, data curation, formal analysis, investigation, original draft, writingreview and editing

Frequently Asked Questions What is GLP-1 and what role does it play in weight management

By far, it has shown the highest average weight loss results in a clinical trial with 22.5% average weight loss at 72 weeks (SURMOUNT-1, NEJM 2022)